These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 31353788)
1. Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node-positive bladder cancer: A retrospective analysis: KCSG GU 17-03. Bae WK; Lee HJ; Park SH; Kim JH; Kim HJ; Maeng CH; Park I; Sohn BS; Kim JA; Lee KH; Lim DH; Chang H; Kim SM; Kim HY; Song H; Lim S; Byun JH; Jung HA Cancer Med; 2019 Sep; 8(12):5431-5437. PubMed ID: 31353788 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of adjuvant chemotherapy for patients who undergo radical cystectomy without neoadjuvant chemotherapy: A retrospective cohort study of 115 advanced bladder cancer patients with pathological lymph node classification. Sakura Y; Yamashita R; Notsu A; Usui K; Shinsaka H; Nakamura M; Matsuzaki M; Niwakawa M Int J Urol; 2024 Jul; 31(7):785-792. PubMed ID: 38606834 [TBL] [Abstract][Full Text] [Related]
3. Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy. Zehnder P; Studer UE; Daneshmand S; Birkhäuser FD; Skinner EC; Roth B; Miranda G; Burkhard FC; Cai J; Skinner DG; Thalmann GN; Gill IS BJU Int; 2014 Apr; 113(4):554-60. PubMed ID: 24131453 [TBL] [Abstract][Full Text] [Related]
4. [The prognostic value of adjuvant and neoadjuvant chemotherapy in total cystectomy for locally advanced bladder cancer]. Habuchi T; Kakehi Y; Terachi T; Ogawa O; Yoshida O Nihon Hinyokika Gakkai Zasshi; 1999 Oct; 90(10):809-17. PubMed ID: 10565159 [TBL] [Abstract][Full Text] [Related]
5. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study. Osawa T; Abe T; Shinohara N; Harabayashi T; Sazawa A; Kubota K; Matsuno Y; Shibata T; Shinno Y; Kamota S; Minami K; Sakashita S; Kumagai A; Mori T; Nonomura K Int J Urol; 2009 Mar; 16(3):274-8; discussion 278. PubMed ID: 19087211 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis. Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A; Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Different Treatment Modalities Outcomes in Clinically Node-positive Bladder Cancer: Analysis of a Population-based Cancer Registry. Staník M; Poprach A; Zapletalová M; Krejčí D; Macík D; Čapák I; Jarkovský J; Lakomý R; Doležel J Clin Genitourin Cancer; 2019 Aug; 17(4):e759-e767. PubMed ID: 31101578 [TBL] [Abstract][Full Text] [Related]
10. Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy. Kaag MG; Milowsky MI; Dalbagni G; Thompson RH; Katz D; Reuter VE; Herr HW; Bajorin D; Bochner BH BJU Int; 2011 Oct; 108(8 Pt 2):E272-7. PubMed ID: 21320277 [TBL] [Abstract][Full Text] [Related]
11. Surgical Pathology Findings in Patients Who Have Undergone Radical Cystectomy/Cystoprostatectomy With Extended Versus Standard Lymph Node Dissection for Urothelial Carcinoma of the Bladder: A Contemporary Analysis. Kagan J; Alemozaffar M; Carthon B; Osunkoya AO Int J Surg Pathol; 2021 Apr; 29(2):150-154. PubMed ID: 32573301 [TBL] [Abstract][Full Text] [Related]
12. Trends in Treatment Strategies and Comparison of Outcomes in Lymph Node Positive Bladder Cancer: An Analysis of the National Cancer Database. Darwish C; Sparks A; Amdur R; Reddy A; Whalen M Urology; 2020 Dec; 146():168-176. PubMed ID: 32866509 [TBL] [Abstract][Full Text] [Related]
13. The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery. Jeong H; Park KJ; Lee Y; Kim HD; Kim JH; Yoon S; Hong B; Lee JL Cancer Res Treat; 2022 Jan; 54(1):226-233. PubMed ID: 33957019 [TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder. Ghoneim IA; Miocinovic R; Stephenson AJ; Garcia JA; Gong MC; Campbell SC; Hansel DE; Fergany AF Urology; 2011 Apr; 77(4):867-70. PubMed ID: 21296399 [TBL] [Abstract][Full Text] [Related]
15. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only. de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076 [TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors of survival in infiltrating urothelial bladder carcinoma. A retrospective study of 158 patients treated by radical cystectomy]. Thieblemont C; Fendler JP; Trillet-Lenoir V; Petris C; Chauvin F; Brunat-Mentigny M; Devaux Y; Devonec M; Gérard JP; Perrin P Bull Cancer; 1996 Feb; 83(2):139-46. PubMed ID: 8652908 [TBL] [Abstract][Full Text] [Related]
17. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]. Słojewski M Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306 [TBL] [Abstract][Full Text] [Related]
18. Impact of adjuvant chemotherapy on patients with pathological Stage T3b and/or lymph node metastatic bladder cancer after radical cystectomy. Tabata M; Ikeda M; Urakami S; Takahashi S; Sakaguchi K; Kurosawa K; Okaneya T Jpn J Clin Oncol; 2015 Oct; 45(10):963-7. PubMed ID: 26130451 [TBL] [Abstract][Full Text] [Related]
19. Editorial Comment on "Effectiveness of adjuvant chemotherapy for patients who undergo radical cystectomy without neoadjuvant chemotherapy: A retrospective cohort study of 115 advanced bladder cancer patients with pathological lymph node classification". Hayakawa N; Kikuchi E Int J Urol; 2024 Jul; 31(7):793-794. PubMed ID: 38757350 [No Abstract] [Full Text] [Related]
20. Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors. Honma I; Masumori N; Sato E; Takayanagi A; Takahashi A; Itoh N; Tamagawa M; Sato MA; Tsukamoto T Urology; 2004 Oct; 64(4):744-8. PubMed ID: 15491713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]